What started in Belgium with a clear ambition to harness the power of microbiome science is now reaching more people across the world.
Today, we are proud to share the next chapter in YUN’s international growth, together with our strong global partner Bausch Health Companies Inc.
Following the launch of YUN in Poland in 2025, our collaboration is now expanding into Mexico, the Czech Republic, Slovakia, Ukraine and Bulgaria. And the journey continues, with Kazakhstan next, planned for October 2026.
For us, this is about much more than entering new markets. It is about making our science led, microbiome friendly approach to skincare available to more people, in more parts of the world.
At the heart of YUN is our proprietary YUN Probiotherapy™ technology platform, built on microbiome science and designed to support the skin’s natural ecosystem.
Seeing a Belgian biotech innovation cross borders and reach new markets is a proud moment for our entire team. And we are excited to take this next step alongside a partner with the global scale, expertise and local presence to make it happen.
Belgian innovation. Global ambition. One mission: bringing microbiome science to more people.
And this is just the beginning.
Read press release of Bausch Health
Bausch Health Companies Inc., a global, diversified pharmaceutical company, and YUN, a Belgian innovator in pioneering probiotherapeutical skincare products, announced the continued expansion of their strategic collaboration in Mexico and across additional EMEA markets following the 2025 launch in Poland.
The expansion includes both portfolio and geographic growth in recent months. In Poland, Bausch Health expanded its dermatology portfolio to include YUN’s eczema-prone skincare solutions, building on last year’s launch of YUN’s probiotic-based skincare solutions for acne-prone skin. Geographic expansion has included launches of YUN’s acne- and eczema-prone skincare solutions in the Czech Republic, Slovakia, Ukraine, Bulgaria, along with the introduction of YUN’s skincare solutions in Mexico. The rollout is expected to continue in Kazakhstan in October 2026. This next phase of the collaboration reflects both companies’ shared ambition to expand access to science-led, microbiome-friendly skincare solutions across EMEA and select international growth markets.
“Following our collaboration in Poland, YUN has entered and is continuing to enter additional markets as part of our broader EMEA growth strategy,” said Cees Heiman, Senior Vice President, Europe & Canada, Bausch Health. “These launches reflect our commitment to bringing differentiated, science-based healthcare and skincare solutions to patients and consumers across the region. EMEA remains a strategically important geography for Bausch Health, and we see strong potential for YUN’s microbiome-focused approach in markets such as Ukraine, Bulgaria, Czech Republic, Slovakia and Kazakhstan.”
“Bringing YUN to Mexico expands our dermatology portfolio with skincare solutions grounded in microbiome science,” said Fernando Zarate, Vice President, Latin America, Bausch Health. “This launch reflects our focus on identifying differentiated products that address evolving skincare needs and broaden access to innovative dermatology offerings in the Mexican market.”
“We are proud to deepen our collaboration with Bausch Health and to see YUN entering additional international markets,” said Tom Verlinden, CEO and Founder of YUN. “Our mission is to harness microbiome science through YUN Probiotherapy™, creating effective, natural and scientifically grounded solutions that respect the body’s own balance. Expanding into Ukraine, Bulgaria, Czech Republic, Slovakia, Kazakhstan, and Mexico allows us to bring that mission to more people together with a partner that combines scale, credibility and strong regional
